T cell profiling reveals high CD4+CTLA-4 + T cell frequency as dominant predictor for survival after prostate GVAX/ipilimumab treatment (Q39300005)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | T cell profiling reveals high CD4+CTLA-4 + T cell frequency as dominant predictor for survival after prostate GVAX/ipilimumab treatment |
scientific article |
Statements
1 reference
T cell profiling reveals high CD4+CTLA-4 + T cell frequency as dominant predictor for survival after prostate GVAX/ipilimumab treatment (English)
1 reference
Tanja D de Gruijl
1 reference
Saskia J A M Santegoets
1 reference
Anita G M Stam
1 reference
Sinéad M Lougheed
1 reference
Helen Gall
1 reference
Petra E T Scholten
1 reference
Martine Reijm
1 reference
Karin Jooss
1 reference
Natalie Sacks
1 reference
Kristen Hege
1 reference
Israel Lowy
1 reference
Jean-Marie Cuillerot
1 reference
B Mary E von Blomberg
1 reference
Rik J Scheper
1 reference
Alfons J M van den Eertwegh
1 reference
Winald R Gerritsen
1 reference
10 August 2012
1 reference
1 reference
62
1 reference
2
1 reference
245-256
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference